Landscapes / Companies
Eddingpharm (Zhuhai) Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials · 1 checked
Trials
3 active
4 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | Nov 2027Phase 2 trial completes | |||
| Next date | Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Homozygous Familial Hypercholesterolemia (HoFH), Mixed Dyslipidemia | ||||
| Open drug page | |||||
GB268not checked |
— |
Phase 1/2 | 1 Aug 2029Phase 1/2 trial completes | ||
| Next date | 1 Aug 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Breast Cancer (Locally Advanced or Metastatic) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021